Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

Sanjay K Gandhi1, Marie M Jensen2, Kathleen M Fox3, Lee Smolen4, Anders G Olsson5, Thomas Paulsson61AstraZeneca LP, Wilmington, DE, USA; 2AstraZeneca, Lund, Sweden; 3Strategic HealthCare Solution, Monkton, MD; 4Medical Decision Modeling Inc, Indianapolis, IN, USA; 5Department of Medical and Health S...

Full description

Bibliographic Details
Main Authors: Gandhi SK, Jensen MM, Fox KM, Smolen L, Olsson AG, Paulsson T
Format: Article
Language:English
Published: Dove Medical Press 2012-01-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/cost-effectiveness-of-rosuvastatin-in-comparison-with-generic-atorvast-a9026